openPR Logo
Press release

Benign Prostate Hyperplasia Bph Market Company Profiles, Segments, Size, Landscape, Demand and Recent Trends, Industry Analysis, Business Outlook, Current and Future Growth By 2031 | Endo International plc, KARL STORZ GMBH & CO.KG, Lumenis

09-26-2024 01:27 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Benign Prostate Hyperplasia Bph Market || 2024-2031

Benign Prostate Hyperplasia Bph Market || 2024-2031

Benign Prostate Hyperplasia (BPH) Market is forecasted to reach at a CAGR of 6 % during the forecast period (2024-2031).

DataM Intelligence has published a new research report on "Benign Prostate Hyperplasia Bph Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. . The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/benign-prostate-hyperplasia-bph-market

The Benign Prostate Hyperplasia Bph market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Benign Prostatic Hyperplasia (BPH) is a non-cancerous condition characterized by the proliferation of prostate gland cells, leading to gland enlargement that compresses the urethra and restricts urine flow. Factors such as aging, hormonal imbalances, and irregular cell growth contribute to this condition. Common symptoms include frequent urination, difficulty initiating urination, weak urinary flow, and incomplete bladder emptying. Currently, men with mild to moderate BPH are primarily treated with medications. The increasing male geriatric population is a key driver for growth in the global BPH therapeutics market.

Market Dynamics:

The increasing geriatric population significantly drives the market for Benign Prostatic Hyperplasia (BPH) treatments, as this condition is increasingly recognized as a health concern among older men. With a projected rise in elderly men, the problem is expected to grow, especially in the United States, where the percentage of those aged 65 and over is anticipated to increase from 16.9% in 2020 to 22% by 2050. By 2030, the World Health Organization estimates that 1 in 6 people will be aged 60 or older, with the global population of this age group expected to double by 2050. Nearly half of men will have histopathologic BPH by age 60, and 90% by age 85, affecting approximately 30 million men globally and 14 million in the U.S. However, the market's growth is hindered by the side effects associated with BPH medications, such as dizziness and orthostatic hypotension, which pose significant risks, particularly for the elderly.

Forecast Growth Projected:

The Global Benign Prostate Hyperplasia Bph Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Benign Prostate Hyperplasia Bph Market:

Endo International plc, KARL STORZ GMBH & CO.KG, Lumenis, Olympus Corporation., Urologix Inc., Boston Scientific Corporation, Coloplast A/S, Lisa Laser, Medifocus Inc, Neotract Inc,

Segment Covered in the Benign Prostate Hyperplasia Bph Market:

By Drug Type: Alpha Blocker, 5-Alpha Reductase Inhibitors

By Surgery: TURP, TUMT, TUNA, Others

By End User: Hospitals, Home Care, Others

Regional Analysis:

The global Benign Prostate Hyperplasia Bph Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/benign-prostate-hyperplasia-bph-market

Regional Analysis:

The global Benign Prostate Hyperplasia Bph Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Benign Prostate Hyperplasia Bph Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Benign Prostate Hyperplasia Bph manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Benign Prostate Hyperplasia Bph in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/benign-prostate-hyperplasia-bph-market

The research study aims to address the following key questions:

➡What is the expected growth rate of the Benign Prostate Hyperplasia Bph Market during the forecast period of 2031?

➡What key factors are driving the Benign Prostate Hyperplasia Bph Market across various regions?

➡Who are the leading vendors in the Benign Prostate Hyperplasia Bph industry, and what strategies contribute to their success?

➡What is the anticipated market scope for the projected period?

➡What major trends are influencing the industry's growth in the coming years?

➡What challenges does the Benign Prostate Hyperplasia Bph Market face?

For Affiliate Market: Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Benign Prostate Hyperplasia Bph Market Company Profiles, Segments, Size, Landscape, Demand and Recent Trends, Industry Analysis, Business Outlook, Current and Future Growth By 2031 | Endo International plc, KARL STORZ GMBH & CO.KG, Lumenis here

News-ID: 3669136 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Cloud Infrastructure Market is growing at a CAGR of 23.8%, CloudSphere announces the launch of Cloud InfraAI Suite | Key Players:- AWS, Hewlett-Packard, Cisco Systems, Google cloud.
Cloud Infrastructure Market is growing at a CAGR of 23.8%, CloudSphere announces …
The Cloud Infrastructure Market is booming, projected to hit over $800 billion by 2034 at a CAGR of 23.8%. Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/cloud-infrastructure-market?pratik Announcement Details:- CloudSphere announces the launch of Cloud InfraAI Suite, a cutting-edge cloud infrastructure platform integrating AI-driven automation for hybrid cloud environments. The event took place in San Francisco, USA - December 11, 2025. This release addresses escalating needs for scalable, secure
Green Data Centres Market is growing at a CAGR of 29.3%, Firmus raised US$327M | Key Players:- ABB Ltd., Asetek, Inc., Delta Electronics, Inc., Digital Realty Trust
Green Data Centres Market is growing at a CAGR of 29.3%, Firmus raised US$327M | …
The green data center market is projected to reach USD 159.75 billion by 2030 from USD 43.26 billion in 2025, at a CAGR of 29.3%. The global green data center market is gaining momentum, driven by rising energy costs, stringent sustainability regulations, and enterprise commitments to carbon reduction. Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/green-data-centres-market?pratik Recent Funding Announcement:- Firmus Technologies (Australia) → Firmus raised US$327M to expand its renewable-powered,
Blood Glucose Test Strips Market Set to Surpass USD 18 Billion by 2031 as Diabetes Epidemic Drives Global Demand | DataM Intelligence
Blood Glucose Test Strips Market Set to Surpass USD 18 Billion by 2031 as Diabet …
The Global Blood Glucose Test Strips Market reached USD 11.0 billion in 2022 and is expected to reach USD 18.8 billion by 2031, growing at a CAGR of 5.96% during the forecast period 2024-2031. This robust growth is primarily driven by the escalating global prevalence of diabetes, increasing awareness and emphasis on regular glucose monitoring for disease management, improving healthcare infrastructure in developing regions, and significant innovations in test strip
Natural Vitamins Market Poised for Strong Growth to USD 13.07 Billion by 2031, Led by Asia-Pacific's Dominant Share | DataM Intelligence
Natural Vitamins Market Poised for Strong Growth to USD 13.07 Billion by 2031, L …
The Global Natural Vitamins Market reached USD 8.33 billion in 2022 and is projected to reach USD 13.07 billion by 2031, growing at a CAGR of 5.8% during the forecast period 2024-2031. This robust growth is driven by a profound consumer shift away from synthetic supplements, rising health consciousness and demand for preventive nutrition, the accelerating trend towards clean-label and organic products across multiple industries, and significant investments by major

All 5 Releases


More Releases for Benign

Rising Geriatric Population Drives Growth Of Benign Prostatic Hypertrophy Drugs …
The Drugs For Benign Prostatic hypertrophy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Drugs For Benign Prostatic hypertrophy Market? The drugs for benign prostatic hypertrophy market has shown strong growth, expanding from $4.28 billion in 2024 to $4.58
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.